{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T19:47:11Z","timestamp":1768420031385,"version":"3.49.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:p>Salivary duct carcinoma (SDC) is a high-grade adenocarcinoma resembling breast ductal carcinoma. It accounts for ~10% of malignant tumors of the salivary glands. Most cases show expression of CK7 and androgen receptor. PAX-8 is a transcription factor, with expression reported in renal, M\u00fcllerian, and thyroid carcinomas. Previous studies have described an absence of PAX-8 immunostaining in most primary salivary gland neoplasms, including SDCs. However, PAX-8 expression is frequently found in neoplasms that can metastasize to salivary glands, suggesting the possibility that this protein can be used to differentiate SDC from secondary neoplastic involvement of the salivary gland. We evaluated the expression of PAX-8 in 14 cases of SDC from our institution. One case showed diffuse moderate to strong PAX-8 positivity, while 2 tumors showed focal weak staining. Therefore, we conclude that although the majority of SDC are negative for PAX-8, rare diffuse positivity can be seen in these primary salivary gland tumors. This could potentially pose difficulty in ruling out metastatic disease from another PAX-8-positive primary neoplasm.<\/jats:p>","DOI":"10.1097\/pai.0000000000000951","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T20:57:20Z","timestamp":1622753840000},"page":"680-684","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["PAX-8 Expression in Salivary Duct Carcinoma"],"prefix":"10.1097","volume":"29","author":[{"given":"Serenella","family":"Serinelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanish","family":"Mirchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Gitto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal K.","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Zaccarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"key":"R1-20250525","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1002\/cncr.21116","article-title":"Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases","volume":"103","author":"Jaehne","year":"2005","journal-title":"Cancer"},{"key":"R3-20250525","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1055\/s-2005-921217","article-title":"Salivary duct carcinoma of the sublingual gland-a case report","volume":"85","author":"Sartorius","year":"2006","journal-title":"Laryngorhinootologie"},{"key":"R4-20250525","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2334\/josnusd.41.129","article-title":"Oral collision carcinoma: salivary duct carcinoma of minor salivary gland origin and squamous cell carcinoma of the oral mucosa","volume":"41","author":"Takeda","year":"1999","journal-title":"J Oral Sci"},{"key":"R5-20250525","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1017\/S0022215105003518","article-title":"Sarcomatoid salivary duct carcinoma of the larynx","volume":"120","author":"Jeong","year":"2006","journal-title":"J Laryngol Otol"},{"key":"R6-20250525","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00405-006-0223-7","article-title":"Salivary duct carcinoma in the sinonasal tract","volume":"264","author":"Higo","year":"2007","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R7-20250525","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ajcp\/109.1.75","article-title":"Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma","volume":"109","author":"Wick","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"R8-20250525","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.mpdhp.2020.01.002","article-title":"Salivary gland tumours: update on molecular diagnostics","volume":"26","author":"Moutasim","year":"2020","journal-title":"Diagn Histopathol"},{"key":"R9-20250525","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/00000478-200308000-00004","article-title":"Mucin-rich variant of salivary duct carcinoma: a clinicopathologic and immunohistochemical study of four cases","volume":"27","author":"Simpson","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R10-20250525","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/014556131209100904","article-title":"Salivary duct carcinoma","volume":"91","author":"Thompson","year":"2012","journal-title":"Ear Nose Throat J"},{"key":"R11-20250525","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12105-013-0442-3","article-title":"GATA3 immunohistochemical expression in salivary gland neoplasms","volume":"7","author":"Schwartz","year":"2013","journal-title":"Head Neck Pathol"},{"key":"R12-20250525","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5858\/arpa.2014-0167-RA","article-title":"Review and updates of immunohistochemistry in selected salivary gland and head and neck tumors","volume":"139","author":"Zhu","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"R13-20250525","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/PAS.0000000000000413","article-title":"Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression","volume":"39","author":"Williams","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R14-20250525","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1365-2559.2003.01600.x","article-title":"Expression of HER-2\/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry","volume":"42","author":"Sk\u00e1lov\u00e1","year":"2003","journal-title":"Histopathology"},{"key":"R15-20250525","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R16-20250525","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2011.3","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study","volume":"24","author":"Ozcan","year":"2011","journal-title":"Mod Pathol"},{"key":"R17-20250525","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12105-014-0546-4","article-title":"Evaluation of PAX2 and PAX8 expression in salivary gland neoplasms","volume":"9","author":"Butler","year":"2015","journal-title":"Head Neck Pathol"},{"key":"R18-20250525","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3892\/ol.2013.1121","article-title":"PAX8 is a novel marker for differentiating between various types of tumor, particularly ovarian epithelial carcinomas","volume":"5","author":"Xiang","year":"2013","journal-title":"Oncol Lett"},{"key":"R19-20250525","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0168-9525(01)02594-X","article-title":"Getting your Pax straight: Pax proteins in development and disease","volume":"18","author":"Chi","year":"2002","journal-title":"Trends Genet"},{"key":"R20-20250525","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/PAI.0000000000000830","article-title":"Lymphoid enhancer binding factor 1 (LEF1) and paired box gene 8 (PAX8): a limited immunohistochemistry panel to distinguish solid pseudopapillary neoplasms and pancreatic neuroendocrine tumors","volume":"28","author":"Lu","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R21-20250525","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/modpathol.2010.176","article-title":"PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma","volume":"24","author":"Sangoi","year":"2011","journal-title":"Mod Pathol"},{"key":"R22-20250525","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0b013e3181da0a20","article-title":"PAX8 expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors","volume":"34","author":"Long","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R23-20250525","doi-asserted-by":"crossref","first-page":"3180798","DOI":"10.1155\/2020\/3180798","article-title":"Immunohistochemical analysis of CD99 and PAX8 in a series of 15 molecularly confirmed cases of Ewing sarcoma","volume":"2020","author":"Chinchilla-T\u00e1bora","year":"2020","journal-title":"Sarcoma"},{"key":"R24-20250525","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/PAI.0000000000000796","article-title":"Comparison of PAX8 expression in breast carcinoma using MRQ50 and BC12 monoclonal antibodies","volume":"28","author":"Singh","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R25-20250525","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAI.0000000000000883","article-title":"PAX8 expression in breast cancer","volume":"29","author":"Lu","year":"2021","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R26-20250525","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/PAI.0000000000000707","article-title":"Unexpected PAX8 immunoreactivity in metastatic high-grade breast cancer","volume":"27","author":"Kilgore","year":"2019","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R27-20250525","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0344-0338(86)80044-9","article-title":"Metastatic tumors to the parotid and submandibular glands-analysis and differential diagnosis of 108 cases","volume":"181","author":"Seifert","year":"1986","journal-title":"Pathol Res Pract"},{"issue":"pt 1","key":"R28-20250525","first-page":"503","article-title":"Metastases to major salivary glands","volume":"99","author":"Batsakis","year":"1990","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R29-20250525","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12105-007-0031-4","article-title":"p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma","volume":"1","author":"McHugh","year":"2007","journal-title":"Head Neck Pathol"},{"key":"R30-20250525","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/jclinpath-2014-202259","article-title":"PAX-8 expression in renal tumours and distant sites: a useful marker of primary and metastatic renal cell carcinoma?","volume":"68","author":"Barr","year":"2015","journal-title":"J Clin Pathol"},{"key":"R31-20250525","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.5858\/arpa.2012-0072-OA","article-title":"PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison","volume":"136","author":"Ozcan","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"R32-20250525","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/cancers10040108","article-title":"Immunohistochemistry for diagnosis of metastatic carcinomas of unknown primary site","volume":"10","author":"Selves","year":"2018","journal-title":"Cancers"}],"container-title":["Applied Immunohistochemistry &amp; Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAI.0000000000000951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T19:04:29Z","timestamp":1748199869000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAI.0000000000000951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pai.0000000000000951","relation":{},"ISSN":["1541-2016"],"issn-type":[{"value":"1541-2016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,3]]},"assertion":[{"value":"2021-01-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}